Helex

New York, NY · Founded 2021 · Privately Held (backing)

Developer of first-in-class genomic medicines designed for renal indications, combining the promise of non-viral targeted delivery and genome editing for the kidney. Helex is based in New York, NY and was founded in 2021. Its last reported valuation was $36.9 million in Oct 2025. It has raised $6.6 million.

Last reported valuation

$36.9M

Oct 2026

Priced at

—

Total raised

$6.6M

Last round

—

How much has Helex raised?

$6.6Macross 0 recorded rounds

Free account

More of Helex with a free account

·Watch Helex: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Helex investors

7 investors are on record for Helex, including SOSV, IndieBio, New York Ventures and Fondation Botnar.

For fundraisers

Raising for a company like Helex?

7 investors have backed Helex.

See all 7 investors →

Frequently asked about Helex

How much has Helex raised?: Helex has raised $6.6M in total across 0 recorded funding rounds.